Results 1 to 10 of about 89 (63)

Me-too pharmaceutical products: History, definitions, examples, and relevance to drug shortages and essential medicines lists. [PDF]

open access: yesBr J Clin Pharmacol, 2020
We define a me‐too drug as a pharmacologically active compound that is structurally related to a first‐in‐class compound, regarded as belonging to the same therapeutic class as the original compound, and used for the same therapeutic purposes, but which may differ in some respects, such as specificity of pharmacological action, adverse reactions ...
Aronson JK, Green AR.
europepmc   +2 more sources

Revisiting the application of Immobilized Artificial Membrane (IAM) chromatography to estimate in vivo distribution properties of drug discovery compounds based on the model of marketed drugs. [PDF]

open access: yesADMET DMPK, 2020
Immobilized Artificial Membrane (IAM) chromatography columns have been used to model the in vivo distribution of drug discovery compounds. Regis Technologies Inc., the manufacturer, had to replace the silica support and consequently introduced a new IAM ...
Valko K, Rava S, Bunally S, Anderson S.
europepmc   +3 more sources

Predicting Dyspnea Inducers by Molecular Topology

open access: yesJournal of Chemistry, Volume 2013, Issue 1, 2013., 2013
QSAR based on molecular topology (MT) is an excellent methodology used in predicting physicochemical and biological properties of compounds. This approach is applied here for the development of a mathematical model capable to recognize drugs showing dyspnea as a side effect.
María Gálvez-Llompart   +4 more
wiley   +1 more source

General access to cubanes as benzene bioisosteres. [PDF]

open access: yesNature, 2023
Wiesenfeldt MP   +10 more
europepmc   +1 more source

Levofloxacin and ciprofloxacin decrease procainamide and N-acetylprocainamide renal clearances. [PDF]

open access: yesAntimicrob Agents Chemother, 2005
Bauer LA   +5 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy